V5 Ultimate
Ultimate
PricingResourcesCompany
English (original)العربيةDeutschΕλληνικάEspañolFrançaisItalianoעברית日本語한국어NederlandsPolskiPortuguêsSvenska
Talk to us Log in Start free trial
Food & Beverage
  • Bakery & Confectionery
  • Food Processing
  • Ingredients & Dry Mixes
  • Sausage & Meat Products
  • Produce Packing
  • Pet Food & Pet Supplements
  • Dairy & Chilled Foods
  • Beverages & Liquid Manufacturing
  • Infant Formula
Pharma & Life Sciences
  • Radiopharmaceuticals
  • Pharmaceutical
  • Medical Devices
  • Veterinary Pharmaceuticals
  • Blood & Tissue
  • Diagnostics & IVD Kits
  • Reference Materials & Standards
  • OTC Topical Creams & Gels
Supplements & Personal Care
  • Dietary Supplements
  • Cosmetics & Personal Care
  • Cannabis & Hemp Manufacturing
  • Fragrances & Perfumery
  • Soaps & Personal Hygiene
  • Botanical Extracts & Essential Oils
Chemicals & Materials
  • Plastics & Resins
  • Agricultural Chemicals
  • Specialty & Industrial Chemicals
  • Printing Inks, Pigments & Construction Chemicals
  • Lubricants & Metalworking Fluids
  • Coatings, Adhesives & Sealants
Other Manufacturing
  • Consumer Products
  • Electronics & Electrical Assembly
  • Textiles & Nonwoven
  • Contract Manufacturing & Co-Packing
  • Packaging & Food-Contact Materials
  • Regulated Warehousing & Distribution
Explore all industries
  • Warehouse & TraceabilityReceive, store, pick and trace
  • Production & PlanningPlan jobs and guide production
  • Quality & LaboratoryTest, investigate and review
  • Documents & TrainingControl procedures and qualifications
  • Equipment & PerformanceMaintain assets and measure losses
  • Orders & IntegrationsConnect customers, suppliers and systems
  • Outputs & InsightsReports, KPIs and label design
Why V5? Product & Features
Why V5?Product & Features
  • Warehouse & TraceabilityReceive, store, pick and trace
  • Production & PlanningPlan jobs and guide production
  • Quality & LaboratoryTest, investigate and review
  • Documents & TrainingControl procedures and qualifications
  • Equipment & PerformanceMaintain assets and measure losses
  • Orders & IntegrationsConnect customers, suppliers and systems
  • Outputs & InsightsReports, KPIs and label design
Explore all industries
    • Bakery & Confectionery
    • Food Processing
    • Ingredients & Dry Mixes
    • Sausage & Meat Products
    • Produce Packing
    • Pet Food & Pet Supplements
    • Dairy & Chilled Foods
    • Beverages & Liquid Manufacturing
    • Infant Formula
    • Radiopharmaceuticals
    • Pharmaceutical
    • Medical Devices
    • Veterinary Pharmaceuticals
    • Blood & Tissue
    • Diagnostics & IVD Kits
    • Reference Materials & Standards
    • OTC Topical Creams & Gels
    • Dietary Supplements
    • Cosmetics & Personal Care
    • Cannabis & Hemp Manufacturing
    • Fragrances & Perfumery
    • Soaps & Personal Hygiene
    • Botanical Extracts & Essential Oils
    • Plastics & Resins
    • Agricultural Chemicals
    • Specialty & Industrial Chemicals
    • Printing Inks, Pigments & Construction Chemicals
    • Lubricants & Metalworking Fluids
    • Coatings, Adhesives & Sealants
    • Consumer Products
    • Electronics & Electrical Assembly
    • Textiles & Nonwoven
    • Contract Manufacturing & Co-Packing
    • Packaging & Food-Contact Materials
    • Regulated Warehousing & Distribution
PricingResourcesCompany
Start free trial Log in Talk to us
HomeGlossaryFilm Coating Process
Manufacturing · The complete guide

Film Coating Process: Steps, Controls and Records for Tablets

In short

Follow tablet cores through preparation, coating, drying and evidence review, separating practical process controls from product-specific regulatory obligations.

4,035 words · ~19 min read
Spray guns applying film coating to tumbling tablets in a coating drum while a gloved operator monitors a tablet
On this page
  1. 01What film coating adds to a tablet
  2. 02US drug CGMP: controls, decisions and equipment records
  3. 03Run the coating sequence from core readiness to discharge
  4. 04Connect coating attributes to measurable process controls
  5. 05Build a traceable coating-batch evidence record
  6. 06Worked reasoning: solids reconciliation and defect origin
  7. 07Transfer the process without copying settings blindly
  8. 08Connect systems and recover from incomplete records
  9. 09Recognise failure patterns without guessing the cause
  10. 10Review readiness, evidence completeness and unresolved decisions
On this page · 10 sections
  1. 1What film coating adds to a tablet
  2. 2US drug CGMP: controls, decisions and equipment records
  3. 3Run the coating sequence from core readiness to discharge
  4. 4Connect coating attributes to measurable process controls
  5. 5Build a traceable coating-batch evidence record
  6. 6Worked reasoning: solids reconciliation and defect origin
  7. 7Transfer the process without copying settings blindly
  8. 8Connect systems and recover from incomplete records
  9. 9Recognise failure patterns without guessing the cause
  10. 10Review readiness, evidence completeness and unresolved decisions
AI · Explain it for MY operation

How does Film Coating Process apply to your shop floor?

Pick your industry and scale — Ask V5 rewrites the definition in your context, gives a worked example, and shows what V5 does on day one.

Your scale

01What film coating adds to a tablet

The film coating process is the controlled application and drying of a film-forming solution or suspension on tablet cores to create a thin, adherent layer with specified surface or performance attributes.

Depending on the formulation and product design, coating can improve appearance, support identification, improve handling, mask taste, protect the core or deliberately modify drug release. These are possible purposes, not properties that every coated tablet possesses. A coating intended for protection needs evidence relevant to that protective function; an acceptable appearance alone does not demonstrate it.

TermWhat it describesRelationship to this processBoundary
Tablet compressionForms the tablet coreProvides the substrate for coatingCore formation, not film formation
Film coatingForms a film on the coreThe operation described hereDoes not inherently imply modified release
Sugar coatingBuilds a sugar-based coveringAnother approach to tablet coatingNot a synonym for film coating
Coating pan speedAn operating variableDescribes pan rotation during processingA setting, not the complete process
Sustained-release coatingA functional coating applicationCan use a film to prolong releaseNot the purpose of all film coatings

The practical boundary is between making the core, applying its film and demonstrating the intended result. A process description explains how the layer is formed; product-specific evaluation establishes whether its surface or performance attributes are achieved. Visual uniformity may support an appearance assessment, but release-modifying intent calls for evidence of release behaviour.

For the narrower topics, see coating pan speed for speed selection and sustained-release coating for release-controlling formulation design. Here, the focus is the overall coating operation rather than a single setting or specialised therapeutic function.

02US drug CGMP: controls, decisions and equipment records

For coating operations, distinguish the legal obligation from the site's chosen implementation. The table maps selected US drug CGMP provisions to practical applications; its final column describes industry practice, not additional regulatory wording. Product-specific in-process controls connect coating execution to meaningful quality decisions.

Jurisdiction and product scopeProvisionBinding obligationCoating-process connection
US drug products under Part 21121 CFR 211.110(a)Establish and follow written procedures describing in-process controls and tests or examinations on appropriate samples of each batch's in-process materials.Practice: define coating-stage sampling, observations and tests in the operating procedure.
US drug products under Part 21121 CFR 211.110(b)Valid in-process specifications for relevant characteristics must be consistent with final drug-product specifications.Practice: connect coating acceptance criteria to the intended finished-tablet attributes rather than appearance alone.
US drug products under Part 21121 CFR 211.110(c)Test in-process materials for identity, strength, quality and purity as appropriate; the quality control unit approves or rejects them.Practice: distinguish an operator's completed coating step from the quality decision on the material.
US drug products under Part 21121 CFR 211.110(d)Identify and control rejected in-process materials under a quarantine system preventing unsuitable manufacturing or processing use.Practice: make rejected coated-tablet status clear at storage and subsequent handling points.
US drug products under Part 21121 CFR 211.67(b)Establish and follow written equipment cleaning and maintenance procedures, including utensils.Practice: address the coater and associated suspension-preparation and delivery equipment.
US drug products under Part 21121 CFR 211.67(c)Keep records of maintenance, cleaning, sanitizing and inspection.Practice: connect equipment records to the equipment used for the coating operation.
US drug products purporting to be sterile under Part 21121 CFR 211.113(b)Establish and follow appropriate written procedures designed to prevent microbiological contamination.Scope boundary: this sterile-product provision is not the basis for ordinary aqueous-coating handling advice.
Dietary supplements, foods, devices, chemicals and markets outside the United StatesProduct- and jurisdiction-specific rulesCheck the current applicable rules before adopting a regulatory control or record framework.Practice: do not transplant this US drug mapping solely because another product uses similar coating equipment.

Keep implementation categories separate

Industry practice: define aqueous-suspension preparation, handling, storage and disposition around the formulation and process risks. This is practical process design, not an extension of the sterile-product row. For supplements, assess in-process specifications within that product category rather than treating drug provisions as interchangeable.

Official guidance: keep agency recommendations distinguishable from binding provisions in site procedures. Industry practice: document why the selected coating checks support the product's quality attributes. Software support: treat electronic workflows as supporting tools, not compliance certification or substitutes for accountable human review, approval and release decisions.

03Run the coating sequence from core readiness to discharge

A typical coating run follows the sequence below, with details governed by the formulation, equipment and authorised manufacturing instructions. This is an operating-practice model; the preceding regulatory section addresses legal obligations.

Purpose and instructions → readiness → liquid preparation → loading and conditioning → spray application → finishing → discharge and reconciliation.

Establish the purpose and instructions

Identify what the film is intended to achieve and which instructions govern the run. Confirm the formulation, batch identity, sampling points and endpoint criteria before execution. Whether using paper or electronic work instructions, capture the instruction version and operator acknowledgements so later reviewers can distinguish planned activities from departures.

Assess core and equipment readiness

Check core identity, quantity, status and visible condition against the instructions. Record pre-existing damage or dust rather than attributing every later defect to coating. Complete line clearance and equipment readiness checks, including the pan, spray assembly, liquid path and air-handling setup. Retain equipment identifiers, cleanliness checks and any unresolved readiness decision.

Prepare the solution or suspension

Connect ingredient identities, lots and actual quantities to the preparation record. Follow the specified mixing sequence and document the resulting solution or dispersion condition. For a coating suspension, consider settling and how mixing continues through transfer and spraying. Record preparation, interruptions and product-specific handling or hold conditions; there is no universal hold time or microbial limit for this workflow.

Load and condition the tablet bed

Record the actual core load and establish tablet movement and airflow using the authorised setup. Conditioning prepares the bed for liquid application; its endpoint depends on the process rather than elapsed time alone. Capture the initial bed condition, relevant readings and the decision to start spraying. These observations provide a baseline for subsequent changes.

Apply spray while managing drying

Liquid delivery, droplet formation, tablet-bed movement and moisture removal work together: tablets need repeated exposure without persistent local overwetting or excessive drying before droplets spread. At spray start, record delivery behaviour and initial tablet appearance. During established operation, retain process readings, observations, samples and adjustments. For interruptions, capture when spraying stopped, whether bed movement and airflow continued, and restart checks. At spray end, record the endpoint evidence and liquid delivered rather than relying only on a pump setting.

Complete product-specific finishing

Routine drying removes remaining water or solvent. A separate curing step, when specified by the formulation, develops the intended film properties and is not simply another name for drying. Record the finishing sequence, relevant observations and endpoint results, including cooling where specified, before deciding the batch is ready for discharge.

Discharge and reconcile

Collect discharge samples at the instructed points and identify receiving containers. Reconcile coated tablets, samples, rejects and losses, alongside suspension prepared, delivered, remaining or discarded. Preserve material genealogy from core and coating-ingredient lots to discharged containers. Close with the equipment handover status, retained residues or materials, and outstanding decisions—not an assumption that discharge itself authorises release.

Tablet Film Coating Workflow
  1. 1
    Define coating purposeAlign intended function, core attributes and acceptance criteria.
  2. 2
    Confirm readinessCheck materials, equipment status, cores and authorised instructions.
  3. 3
    Prepare suspensionRecord ingredient identity, preparation conditions and handling.
  4. 4
    Condition Tablet BedEstablish documented starting conditions before spray application.
  5. 5
    Spray and DryTrack process trends, samples and relevant interruptions.
  6. 6
    Finish and ReconcileComplete specified finishing and reconcile material quantities.
  7. 7
    Review dispositionAssemble linked evidence for accountable human decisions.
A typical sequence; product-specific instructions determine settings and hold points.

04Connect coating attributes to measurable process controls

A practical control map starts with the intended coating function and relevant critical quality attributes, then connects them to observable process behaviour. The table below is a development aid, not a prescribed regulatory format; responses depend on the formulation, equipment and established process.

Product attributePotential process influenceMeasurement or observationProduct-specific response
CoverageSuspension solids, spray delivery, spray distribution, load and bed movementExposed areas; coverage variation across sampled tabletsInvestigate distribution and mixing before extending application.
AppearanceSuspension condition, atomisation and drying balanceColour variation, roughness, sticking or logo bridgingCompare defects with suspension checks and spray observations.
AdhesionCore surface condition, wetting and tablet-bed temperaturePeeling, flaking or damage during handlingAssess core–film compatibility and drying history.
Moisture-related conditionAirflow, incoming-air condition and liquid deliveryProduct moisture results, tackiness and drying trendsEvaluate moisture removal against product-specific targets.
Performance appropriate to coating purposeFilm composition, deposition uniformity and any curing stageDisintegration, dissolution or protective-function testing, as appropriateUse relevant performance results rather than appearance alone.

These are candidate influences, not an automatic list of critical process parameters. A critical designation needs a product-specific rationale linking parameter variability to a quality attribute, supported by development evidence and risk assessment. Coating pan speed belongs within the assessment of bed movement; its significance depends on the load and equipment rather than its presence on the control screen.

Inlet-air temperature describes incoming drying air; outlet-air temperature describes exiting air after heat and moisture exchange. Tablet-bed temperature describes the product bed at the measurement location. Sensor position and measurement method affect interpretation, so these readings are not interchangeable.

Keep decision categories separate: a setpoint is the commanded target; an operating observation is what was measured or seen; an alert condition prompts assessment; an acceptance criterion defines an acceptable result. Meeting a setpoint does not itself demonstrate product acceptance. There are no universal coating settings: temperature, speed, spray rate and weight-gain targets need product- and equipment-specific justification.

05Build a traceable coating-batch evidence record

A useful coating record connects batch identity and instruction revision to the evidence needed for review. The model below is a proposed record design, not a legally prescribed database schema. Within the batch manufacturing record, use stable identifiers to connect core lots, coating ingredients, preparation history, equipment readiness, execution events, samples, results and human review decisions.

Evidence groupUseful fieldsRelationshipReview question
Batch and instructionsBatch ID; product; instruction revisionParent context for coating activitiesWhich instructions governed this run?
Materials and preparationCore lot IDs; ingredient IDs and lots; quantities and units; preparation timestamps; operatorPreparation ID links ingredients to coating feed and batchWhat was prepared and used?
Equipment readinessCoater and accessory IDs; cleaning, maintenance and inspection references; status timestampsEquipment history linked to time of useWas readiness supported when loading began?
ExecutionEvent timestamps; parameter names; prescribed and observed values; units; instrument references; exception referencesEvents linked to batch, phase and equipmentWhat actually happened, and when?
Sampling and resultsSample IDs; locations; collection times; raw results and units; method and specification revisionsSample linked to execution phase and assessmentDoes the result represent the intended material?
Review and decisionsReviewer identity; assessment; decision timestamp; rationale; exception references; disposition statusDecision linked to evidence reviewedWhat was decided, by whom, and why?

As in the setpoint-versus-observation distinction above, record each execution field as either a prescribed value or a measured result, not a merged entry. Identify what each measurement represents, with units and its instrument reference. For sample traceability through production context, connect collection location and time to the relevant batch phase rather than relying on a sample label alone.

Likewise, retain raw results separately from assessed results, including the method and specification revisions used for interpretation. Process completion records that coating ended; disposition records a human decision about the material. Linked cleaning and maintenance histories help reviewers establish readiness at use, rather than infer it from an equipment status displayed later.

For corrections, a practical data integrity design preserves the original entry and context alongside the corrected value, author, timestamp and reason. Link the correction to affected results, assessments or exceptions so reviewers can reconstruct its significance without silently rewriting the execution history.

Coating Batch Evidence Relationships

Batch Context

Connects product, core lot and instruction revision.

  • batch_id
  • product_id
  • core_lot_id
  • instruction_revision
  • coater_id
  • batch_status

Suspension Preparation

Links ingredients, preparation history and measured solids.

  • preparation_id
  • batch_id
  • ingredient_lot_ids
  • prepared_at
  • solids_mass_fraction
  • suspension_mass_kg

Execution Evidence

Connects trends, equipment readiness and interventions.

  • event_id
  • batch_id
  • occurred_at
  • equipment_record_id
  • parameter_tag
  • parameter_value
  • parameter_unit

Sample result

Ties observations to sampling context and specifications.

  • sample_id
  • batch_id
  • sampling_stage
  • method_revision
  • specification_revision
  • result_value
  • result_unit

Review decision

Links exceptions to accountable human assessment.

  • review_id
  • batch_id
  • deviation_ids
  • reviewer_id
  • decision
  • decided_at
A proposed model connecting execution evidence with samples and human decisions.

06Worked reasoning: solids reconciliation and defect origin

Case: suspension delivered is not coating deposited

Assume a homogeneous suspension, a measured net quantity actually sprayed, and a dry-solids fraction representative of that sprayed material. Express suspension mass in kg and dry-solids mass fraction in kg/kg. These are illustrative material-balance assumptions, not operating specifications.

Dry solids sprayed (kg) = suspension sprayed (kg) × dry-solids mass fraction (kg/kg).

The suspension-mass units cancel, leaving kg of dry solids delivered through the spray. Tank depletion alone does not establish the assumed net sprayed quantity: reconcile line hold-up, samples, spills and returned suspension before using it. A representative solids measurement also depends on the mixing and sampling basis described in coating suspension preparation.

Next, examine collection losses, equipment deposits, overspray and solids associated with rejected tablets. Express losses on a comparable dry-solids basis and avoid double-counting material. Product mass gain may provide corroborating evidence, but changes in core moisture or tablet loss can complicate that comparison. Use in-process reconciliation to distinguish measured quantities from estimates and unexplained differences.

The bounded conclusion is an estimate of delivered dry solids under the stated assumptions. It is not proof of deposited film mass, complete recovery or uniform coating across tablets.

Case: distinguish core damage from a coating-stage defect

Assume an aqueous, non-release-modifying coating and comparable pre-coat and post-coat observations. Label samples by stage: core-before-loading, coating-in-process and post-coat-discharge. Record categorical observations such as chipped edges, tacky joined surfaces and intact surfaces, rather than combining them into a single defective-tablet category.

Edge damage visible before loading supports a pre-existing contribution; it does not exclude additional damage during coating. Newly observed tacky joined surfaces suggest a coating-stage contribution. Align their first observation with spray interruptions, suspension changes, airflow events and discharge handling. If comparing temperature trends, identify the measurement location and use °C.

Next discriminating evidence includes retained core images, stage-specific defect observations, nozzle inspection findings and aligned spray and drying records. Excess surface wetness is a plausible mechanism for joining, not demonstrated causation merely because an event occurred nearby. The coating-defect reference helps separate defect descriptions.

The material-review question is whether the affected population and its acceptability can be established from the observations and product criteria. Refer to the exception-recovery section for incomplete or conflicting records; a plausible explanation alone does not settle disposition.

07Transfer the process without copying settings blindly

For film coating, technology transfer commonly compares core properties and coating formulation alongside coater geometry, load, spray coverage, nozzle arrangement, air handling and bed movement. Matching a displayed setting alone does not establish equivalent tablet exposure or drying behaviour: different equipment can distribute spray, circulate tablets and move drying air differently. Treat setpoint matching as a starting comparison, not evidence of process equivalence.

Compact transfer-package checklist

  • Instruction mapping: connect sending-site instructions to receiving-site operations; identify changed terminology, control modes and decision points.
  • Material references: identify core and coating-material specifications, formulation versions and relevant differences in core size, shape, surface condition or suspension properties.
  • Equipment differences: compare geometry, working load, nozzle positions, spray overlap, air distribution and observed bed movement.
  • Measurement mapping: align parameter definitions, measurement locations, instrument units and whether each recorded value represents a setpoint or a measured condition.
  • Control rationale: explain how proposed settings address coating attributes; compare sampling strategies, test methods, product attributes and observed variability.
  • Unresolved questions: record uncertain comparisons, evidence needed, accountable reviewers and decisions still pending.

A matching average coating weight gain can conceal different tablet-to-tablet distributions. Compare individual results and sampling coverage where informative, rather than relying only on batch averages. Evidence of similar averages supports an aggregate comparison; it does not, by itself, demonstrate similar coating distribution.

08Connect systems and recover from incomplete records

As an integration design practice, connect weighing records, coater controls or historians, laboratory results and exception-management records through shared batch and equipment keys. Carry timestamps, units and source-record identifiers with each transfer so reviewers can associate a coating-suspension addition, process trend, sample result and investigation without relying on screen labels alone. Keep sample-collection time distinguishable from result-entry time.

Reconciliation commonly checks for missing readings, duplicate transfers, clock mismatches, unit mismatches and inconsistent batch identifiers. A transfer failure is not itself a confirmed process excursion; conversely, a successful import does not establish that processing was acceptable. Preserve original values, source context and any documented mapping or conversion. Use an audit trail review workflow to examine corrections, and route unresolved conflicts through the deviation-management interface for assessment rather than silently selecting the more convenient record.

For interruption recovery, a practical sequence is to identify the affected material and time window, compare available evidence with the applicable coating instructions, and document the authorised next action. Record who assessed the gap, what evidence supported the decision and which uncertainty remains. Recovery planning should address both the interrupted operation and incomplete data transfer; restoring connectivity alone does not resolve either assessment. Software can support capture and routing, but status changes do not replace the human decisions covered above.

09Recognise failure patterns without guessing the cause

In coating troubleshooting, similar appearances can have different causes. Treat these contributors as hypotheses; use the evidence column to choose checks that distinguish them before changing settings.

ObservationPlausible contributorsEvidence to examineControl or review action
Rough surfacesAgglomerated suspension; droplets drying before spreadingSuspension condition: preparation, mixing and hold historyCheck dispersion condition alongside drying trends.
Uneven coverageRestricted nozzle; uneven spray overlap or bed exposureSpray distribution: nozzle inspections and spray-pattern observationsInspect delivery and tablet movement before adjusting spray rate.
Colour variationIncorrect colourant; material-lot differences; pigment settlingMaterial identity: dispensing records and coating-material lot traceabilityReconcile identities before investigating mixing and deposition.
AbrasionFragile cores; excessive mechanical handlingCore condition: incoming defects, friability results and transfer observationsCompare pre-coating damage with when defects first appeared.
Unresolved equipment-readiness statusMissing cleaning entry; open maintenance work; conflicting status labelsEquipment records: cleaning, maintenance and pre-use checksResolve status before use; review cleaning verification after any applicable clean-in-place cycle.

For joined tablets, use the worked case above rather than treating appearance as proof of a single cause. Another practical mistake is accepting end-of-run appearance while overlooking contradictory process trends or test results. Review those conflicts together; the FAQ addresses appearance versus dissolution.

10Review readiness, evidence completeness and unresolved decisions

Use these questions as a practical implementation aid, not a compliance declaration or substitute for authorised review.

Before processing

  • Is the coating purpose clear, as defined in What film coating adds to a tablet?
  • Is the intended instruction revision available, with relevant change control decisions resolved?
  • Are core and coating-material identities confirmed against the execution instructions?
  • Is equipment readiness documented at the checkpoints described in Run the coating sequence?
  • Are measurement units, methods and sampling locations defined as discussed in Connect coating attributes to measurable process controls?

Before disposition

  • Does sampling cover the planned stages and any interruptions identified during execution?
  • Does material reconciliation explain the streams considered in Worked reasoning?
  • Are unresolved exceptions visible, with evidence gaps handled through the exception-recovery approach?
  • Is review ownership clear for results, exceptions and the disposition decision in the coating-batch evidence record?

For specialised edge cases, use the FAQs below.

Frequently asked questions

Q.What changes when incoming tablet cores have a different moisture condition?+

A practical assessment starts by comparing core moisture with the condition used to establish the coating process, including the test method and storage history. Different moisture can change how cores tolerate wetting and drying, so an unchanged recipe may not produce the same result. Review moisture as a potential critical material attribute, then assess conditioning, sticking, erosion and drying behaviour. Adjustments to inlet air temperature are best evaluated alongside airflow and spray delivery, rather than used as an isolated correction.

Q.Can a pigment or coating-material change matter even when the finished colour looks the same?+

Yes. In coating practice, matching colour does not establish equivalent material behaviour. A pigment or coating-system change can affect suspension dispersion, settling, viscosity, spray delivery or film formation without an obvious visual difference on the tablet. A practical change-control assessment compares material specifications, supplier information, preparation behaviour and relevant tablet performance. Include coating suspension preparation in the comparison: an apparently interchangeable material may behave differently during mixing, holding or transfer to the spray system.

Q.How should samples from different portions of a coating-batch discharge be identified and compared?+

A practical sampling plan assigns each sample the batch identity, discharge portion, collection time and receiving container, with a traceable link to its test results. Define the discharge portions before collection rather than reconstructing them afterward. Sample login and handoff can structure that identification. Compare individual results and their distribution against the same applicable criteria; an overall average may conceal a local difference. For a coating-uniformity assessment, keep portion identities visible instead of combining all material into an undifferentiated composite.

Q.Why can acceptable coating appearance coexist with an unresolved dissolution concern?+

As described in What film coating adds to a tablet, appearance and performance are separate boundaries; a smooth, evenly coloured film does not establish permeability, behaviour in the test medium or interaction with the core. For sustained-release coatings, that distinction can be particularly important. A practical investigation compares dissolution results with material changes, coating distribution, drying or curing history, and core properties, rather than treating visual acceptance as an explanation for an unresolved performance result.

Q.When does reusing a remaining coating suspension need a separate assessment?+

A separate assessment is typically appropriate when reuse introduces a different holding period, storage condition, transfer route or recipient batch from the established process. Review suspension identity, settling, redispersibility, contamination exposure and traceability before treating the remainder as usable. For US nonsterile drugs, 21 CFR 211.113(a) requires written procedures designed to prevent objectionable microorganisms to be established and followed. A practical bioburden-monitoring approach considers the suspension’s formulation and handling; acceptable colour or successful remixing alone does not establish microbiological suitability.

Q.How should an in-process result outside its specification be assessed before the batch proceeds?+

As covered in the regulatory section, US drug in-process materials must be tested as appropriate and approved or rejected by the quality control unit, with rejected material identified and controlled under quarantine. A practical out-of-specification assessment starts by preserving the result, identifying affected material and reviewing sampling, testing and process events. Document the rationale for further testing and the batch's next step rather than treating a passing repeat as sufficient explanation.

Q.How should a revised coating instruction be handled during an active batch?+

As the regulatory section notes, written procedures for in-process controls must be established and followed. A practical document-control workflow distinguishes a proposed revision from the instruction authorised for the active batch. Record the reason, review, effective point and affected material before implementing an authorised change. Preserve which instruction governed each completed operation in the batch execution history; replacing the displayed instruction alone can obscure what operators actually followed.

Q.How can a contract manufacturer and product owner agree who reviews coating evidence?+

A practical quality agreement assigns responsibility by evidence type and decision, rather than simply saying both parties review the batch. Specify who examines material suitability, process trends, sample results, deviations and unresolved questions, and who communicates the disposition. Define how each reviewer accesses the underlying records and how disagreements are escalated. A shared batch-release checklist can make those handoffs explicit. Keep review completion separate from approval authority: a transferred file or completed checklist is not itself a human release decision.

Primary sources

  • 21 CFR 211.110
  • 21 CFR 211.113
  • 21 CFR 211.67
Software that covers Film Coating Process
V5 Ultimate Cosmetics Manufacturing
Formulation with allergen and INCI awareness, batch record with in-process control, ISO 22716 GMP evidence, MoCRA facility…
Talk to us about Film Coating Process

Want to see how Film Coating Process could fit into your own records and workflows? Explore the related V5 pages or talk to our team about what applies to your operation.

Start free
Back to glossary
Related terms
  • → ISA-88
  • → EWI
  • → Genealogy
  • → OEE
  • → API
  • → Excipient
  • → Line Clearance
  • → BOM

Next Step

Try V5 with your own records, or ask a question first. Ask V5 opens with an editable question; nothing is sent until you choose to.

Start your free trial Browse All Features

Showing the site for the United States. Local spelling, dates and prices are applied automatically; change the language at the top of the page.

V5 Ultimate
Ultimate

Warehouse, quality and manufacturing software for regulated operations.

ProductIndustriesPricingResourcesSecurity & TrustCompanyLegal Centre

© S.G. Systems, LLC